FDA Hits Vital Connections for Validation Procedures

June 21, 2018

The FDA issued a Form 483 to Vital Connections, citing the medical device manufacturer on process and design validation procedures.

The FDA issued the form after a March 2018 inspection of the firm’s Tipp City, Ohio, facility. Investigators found the facility did not maintain process validation procedures and had not conducted validation activities for any of its production processes, including mold press operations used to manufacture plastic connectors and snaps.

Investigators found the company’s design control validation procedure did not ensure that the validation followed pre-established protocols. In July 2015, the company sent product not yet available for sale to several local hospitals without developing a protocol to ensure that design validation activities were adequately completed or setting parameters to be tested.

View today's stories